| PRVB Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the PRVB shares outstanding history going back to 8/9/2018:
Also see: PRVB Market Cap History PRVB YTD Return |
As of 3/20/2023 Provention Bio has 94.78 million PRVB shares outstanding. Investors often track the PRVB shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows PRVB share count trends over time, with 21 historical shares outstanding datapoints presented, dating back to 8/9/2018.

| PRVB Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the PRVB shares outstanding history going back to 8/9/2018:
Also see: PRVB Market Cap History PRVB YTD Return |
| PRVB Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||
PRVB Historical Shares Outstanding: +22.36% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||
| PRVB Stock Price Chart |
| About Provention Bio Inc |
| Provention Bio is a clinical stage biopharmaceutical company. Co.'s primary asset, TZIELD, is approved to delay the onset of Stage 3 Type 1 Diabetes (T1D) in adult and pediatric patients aged eight years and older with Stage 2 T1D. Co. is also developing TZIELD for use in Stage 3 newly diagnosed T1D patients, for which Co. has an ongoing phase three clinical trial, the PROTECT study. Co.'s product portfolio also include: PRV-3279, which is a humanized bispecific scaffold molecule targeting the B-cell surface proteins, an inhibitory Fc receptor for the treatment of systemic lupus erythematosus and for the prevention of immunogenicity of biotherapeutics such as those used in gene therapy. We show 21 historical shares outstanding datapoints in our coverage of PRVB's shares outstanding history. Understanding the changing numbers of PRVB shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like PRVB versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching PRVB by allowing them to research PRVB shares outstanding history as well as any other stock in our coverage universe. |
| PRVB Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| PRVB Share Performance |
| Shares Outstanding Peers |
| Provention Bio (PRVB) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
PRVL Shares Outstanding History PSNL Shares Outstanding History PSTI Shares Outstanding History PSTV Shares Outstanding History PSTX Shares Outstanding History PTCT Shares Outstanding History PTE Shares Outstanding History PTGX Shares Outstanding History PTI Shares Outstanding History PTIE Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.